<!DOCTYPE html
  PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:n1="urn:hl7-org:v3">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
      <title>Thrombolytic Therapy</title><style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
}

a {
	color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);
}

h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}

div {
	width: 80%;
}

table {
	line-height: 10pt;
	width: 80%;
}

tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}

.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}
pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}
	</style></head>
   <body>
      <table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Title</span></td>
               <td width="80%" colspan="3">Thrombolytic Therapy</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Identifier<br>(Measure Authoring Tool)</span></td>
               <td width="30%">91</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Version number</span></td>
               <td width="30%">4</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">NQF Number</span></td>
               <td width="30%">0437</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">GUID</span></td>
               <td> 2838875a-07b5-4bf0-be04-c3eb99f53975</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement Period</span></td>
               <td width="80%" colspan="3">January 1, 20xx  through December 31, 20xx </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Steward</span></td>
               <td width="80%" colspan="3">Joint Commission</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Developer</span></td>
               <td width="80%" colspan="3">Joint Commission</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Endorsed By</span></td>
               <td width="80%" colspan="3">National Quality Forum</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Description</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Acute ischemic stroke patients who arrive at this hospital within 2 hours of time last known well and for whom IV t-PA was initiated at this hospital within 3 hours of time last known well.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Copyright</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Measure specifications are in the Public Domain.

LOINC(R) is a registered trademark of the Regenstrief Institute.

This material contains SNOMED Clinical Terms (R) (SNOMED CT(c)) copyright 2004-2010 International Health Terminology Standards Development Organization. All rights reserved.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Disclaimer</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Scoring</span></td>
               <td width="80%" colspan="3">Proportion</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Type</span></td>
               <td width="80%" colspan="3">Process</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Stratification</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Risk Adjustment</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rate Aggregation</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rationale</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>The administration of thrombolytic agents to carefully screened, eligible patients with acute ischemic stroke has been shown to be beneficial in several clinical trials. These included two positive randomized controlled trials in the United States: The National Institute of Neurological Disorders and Stroke (NINDS) Studies, Part I and Part II. Based on the results of these studies, the Food and Drug Administration (FDA) approved the use of intravenous recombinant tissue plasminogen activator (IV r-TPA or t-PA) for the treatment of acute ischemic stroke when given within 3 hours of stroke symptom onset. A large meta-analysis controlling for factors associated with stroke outcome confirmed the benefit of IV t-PA in patients treated within 3 hours of symptom onset. While controversy still exists among some specialists, the major society practice guidelines developed in the United States all recommend the use of IV t-PA for eligible patients. Physicians with experience and skill in stroke management and the interpretation of CT scans should supervise treatment.

The European Cooperative Acute Stroke Study (ECASS) III trial indicated that intravenous rtPA can be given safely to, and can improve outcomes for, carefully selected patients treated 3 to 4.5 hours after stroke; however, as the NINDS investigators concluded, the earlier that IV thrombolytic therapy is initiated, the better the patient outcome. Therefore, the target for IV t-PA initiation remains within 3 hours of time last known well. The administration of IV thrombolytic therapy beyond 3 hours of stroke symptom onset has not been FDA approved.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Clinical Recommendation Statement</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>The administration of thrombolytic agents to carefully screened, eligible patients with acute ischemic stroke has been shown to be beneficial in several clinical trials. Intravenous recombinant tissue plasminogen activator (IV r-TPA or t-PA) should be used for the treatment of acute ischemic stroke when given within 3 hours of stroke symptom onset.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Improvement Notation</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>An increase in the rate</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>del Zoppo GJ, Saver JL, Jauch EC, Adams HP. Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator: A Science Advisory From the American Heart Association/ American Stroke Association. Stroke. 2009;40:2945-2948.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Guyatt, G. H., E. A. Akl, M. Crowther, D. D. Gutterman, H. J. Schuunemann, Therapy American College of Chest Physicians Antithrombotic, and Panel Prevention of Thrombosis. "Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines." [In eng]. Chest 141, no. 2 Suppl (Feb 2012): 7S-47S.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Jauch, E. C., J. L. Saver, H. P. Adams, Jr., A. Bruno, J. J. Connors, B. M. Demaerschalk, P. Khatri, et al. "Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association." [In Eng]. Stroke  (Jan 31 2013).</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Kwiatkowski, T. G., R. B. Libman, M. Frankel, B. C. Tilley, L. B. Morgenstern, M. Lu, J. P. Broderick, et al. "Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group." [In eng]. N Engl J Med 340, no. 23 (Jun 10 1999): 1781-7.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Saposnik, G., J. Fang, M. K. Kapral, J. V. Tu, M. Mamdani, P. Austin, S. C. Johnston, Network Investigators of the Registry of the Canadian Stroke, and Group Stroke Outcomes Research Canada Working. "The Iscore Predicts Effectiveness of Thrombolytic Therapy for Acute Ischemic Stroke." [In eng]. Stroke 43, no. 5 (May 2012): 1315-22.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>"Tissue Plasminogen Activator for Acute Ischemic Stroke. The National Institute of Neurological Disorders and Stroke Rt-Pa Stroke Study Group." [In eng]. N Engl J Med 333, no. 24 (Dec 14 1995): 1581-7.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Wardlaw, J. M., V. Murray, E. Berge, and G. J. Del Zoppo. "Thrombolysis for Acute Ischaemic Stroke." [In eng]. Cochrane Database Syst Rev, no. 4 (2009): CD000213.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Guidance</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>The unit of measurement for this measure is an inpatient episode of care. Each distinct hospitalization should be reported, regardless of whether the same patient is admitted for inpatient care more than once during the measurement period. In addition, the eMeasure logic intends to represent events within or surrounding a single occurrence of an inpatient hospitalization.

The &#8220;baseline state&#8221; value set and its associated effectiveTime intend to capture the date and time prior to hospital arrival at which it was witnessed or reported that the patient was last known to be without the signs and symptoms of the current stroke or at his or her baseline state of health. The time of symptom onset value set and its associated effectiveTime is intended to capture the date and time at which symptoms started if symptom onset was witnessed. Since none of the value sets make any specific reference to stroke, their use is only meaningful in the context of stroke-specific documentation, such as a stroke assessment form or template. 

The &#8220;Non-elective Inpatient Encounter&#8221; value set intends to capture all non-scheduled hospitalizations. This value set is a subset of the &#8220;Inpatient encounter&#8221; value set, excluding concepts that specifically refer to elective hospital admissions. Non-elective admissions include emergency, urgent and unplanned admissions, including patients admitted for observation.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Transmission Format</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Initial Patient Population</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Patients age 18 and older discharged from inpatient care (non-elective admissions) with a principal diagnosis of ischemic or hemorrhagic stroke and a length of stay less or equal to 120 days.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Ischemic stroke patients admitted through the Emergency Department whose time of arrival is within 2 hours (less than or equal to 120 minutes) of 1) time they were known to be at their baseline state of health; or 2) time of symptom onset if time last known at baseline state is not known.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator Exclusions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Numerator</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Acute ischemic stroke patients for whom IV thrombolytic therapy was initiated at this hospital within 3 hours (less than or equal to 180 minutes) of when it was witnessed or reported that the patient was last known to be without the signs and symptoms of the current stroke or at his or her baseline state of health.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Numerator Exclusions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator Exceptions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Patients with a documented Reason For Not Initiating IV Thrombolytic.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Population</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Observations</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Supplemental Data Elements</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</pre></div>
               </td>
            </tr>
         </tbody>
      </table>
      <h2><a name="toc">Table of Contents</a></h2>
      <ul>
         <li><a href="#d1e555">Population criteria</a></li>
         <li><a href="#d1e2700">Data criteria (QDM Data Elements)</a></li>
         <li><a href="#d1e3603">Reporting Stratification</a></li>
         <li><a href="#d1e3625">Supplemental Data Elements</a></li>
      </ul>
      <hr align="left" color="teal" size="2" width="80%">
      <h3><a name="d1e555" href="#toc">Population criteria</a></h3>
      <div>
         
         <ul>
            <li>
               <b>Initial Patient Population =</b>
               
               <ul>
                  <li>AND: "Patient Characteristic Birthdate: birth date"  &gt;= 18 year(s) starts before start of "Occurrence A of Encounter, Performed:
                     Non-Elective Inpatient Encounter"
                  </li>
                  <li>AND: "Occurrence A of Encounter, Performed: Non-Elective Inpatient Encounter (length of stay &lt;= 120 day(s))"</li>
                  <li>AND: "Occurrence A of Encounter, Performed: Non-Elective Inpatient Encounter" ends during "Measurement Period"</li>
                  <li>AND: 
                     <ul>
                        <li>OR: "Diagnosis, Active: Ischemic Stroke (ordinality: 'Principal')"</li>
                        <li>OR: "Diagnosis, Active: Hemorrhagic Stroke (ordinality: 'Principal')"</li>
                        <li> starts during "Occurrence A of Encounter, Performed: Non-Elective Inpatient Encounter"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator =</b>
               
               <ul>
                  <li>AND: "Initial Patient Population"</li>
                  <li>AND: "Diagnosis, Active: Ischemic Stroke (ordinality: 'Principal')" starts during "Occurrence A of Encounter, Performed: Non-Elective
                     Inpatient Encounter"
                  </li>
                  <li>AND: "Occurrence A of Encounter, Performed: Emergency Department Visit"  &lt;= 1 hour(s) ends before start of "Occurrence A of
                     Encounter, Performed: Non-Elective Inpatient Encounter"
                  </li>
                  <li>AND: 
                     <ul>
                        <li>OR: "Occurrence A of Physical Exam, Finding: Baseline State"  &lt;= 120 minute(s) ends before start of "Occurrence A of Encounter,
                           Performed: Emergency Department Visit"
                        </li>
                        <li>OR: "Occurrence A of Physical Exam, Finding: Time of Symptom Onset"  &lt;= 120 minute(s) starts before start of "Occurrence A
                           of Encounter, Performed: Emergency Department Visit"
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exclusions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
            <li>
               <b>Numerator =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: "Medication, Administered: Thrombolytic (t-PA) Therapy (route: 'Intravenous route')"  &lt;= 180 minute(s) starts after end
                           of "Occurrence A of Physical Exam, Finding: Baseline State"
                        </li>
                        <li>OR: "Medication, Administered: Thrombolytic (t-PA) Therapy (route: 'Intravenous route')"  &lt;= 180 minute(s) starts after start
                           of "Occurrence A of Physical Exam, Finding: Time of Symptom Onset"
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exceptions =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: 
                           <ul>
                              <li>OR: "Laboratory Test, Result: Prothrombin Time (result &gt; 15 second(s))"</li>
                              <li>OR: "Laboratory Test, Result: INR (result &gt; 1.7 )"</li>
                              <li>OR: "Laboratory Test, Result: Platelet Count (result &lt; 100000 )"</li>
                              <li>OR: "Laboratory Test, Result: Partial Thromboplastin Time (result &gt; 40 second(s))"</li>
                              <li>OR: "Physical Exam, Finding: Systolic Blood Pressure (result &gt; 185 mmHg)"</li>
                              <li>OR: "Physical Exam, Finding: Diastolic Blood Pressure (result &gt; 110 mmHg)"</li>
                              <li>OR: "Risk Category Assessment: National Institute of Health Stroke Scale (result = 0 )"</li>
                              <li>OR: "Risk Category Assessment: National Institute of Health Stroke Scale (result &gt; 22 )"</li>
                              <li>OR: "Medication, Order not done: Medical Reason" for "t-PA ingredient specific "</li>
                              <li>OR: "Medication, Order not done: Patient Refusal" for "Thrombolytic (t-PA) Therapy "</li>
                              <li>OR: "Medication, Administered not done: Medical Reason" for "Thrombolytic (t-PA) Therapy "</li>
                              <li>OR: "Medication, Administered not done: Patient Refusal" for "Thrombolytic (t-PA) Therapy "</li>
                              <li>  &lt;= 180 minute(s) starts after end of "Occurrence A of Physical Exam, Finding: Baseline State"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>OR: "Laboratory Test, Result: Prothrombin Time (result &gt; 15 second(s))"</li>
                              <li>OR: "Laboratory Test, Result: INR (result &gt; 1.7 )"</li>
                              <li>OR: "Laboratory Test, Result: Platelet Count (result &lt; 100000 )"</li>
                              <li>OR: "Laboratory Test, Result: Partial Thromboplastin Time (result &gt; 40 second(s))"</li>
                              <li>OR: "Physical Exam, Finding: Systolic Blood Pressure (result &gt; 185 mmHg)"</li>
                              <li>OR: "Physical Exam, Finding: Diastolic Blood Pressure (result &gt; 110 mmHg)"</li>
                              <li>OR: "Risk Category Assessment: National Institute of Health Stroke Scale (result = 0 )"</li>
                              <li>OR: "Risk Category Assessment: National Institute of Health Stroke Scale (result &gt; 22 )"</li>
                              <li>OR: "Medication, Order not done: Medical Reason" for "t-PA ingredient specific "</li>
                              <li>OR: "Medication, Order not done: Patient Refusal" for "Thrombolytic (t-PA) Therapy "</li>
                              <li>OR: "Medication, Administered not done: Medical Reason" for "Thrombolytic (t-PA) Therapy "</li>
                              <li>OR: "Medication, Administered not done: Patient Refusal" for "Thrombolytic (t-PA) Therapy "</li>
                              <li>  &lt;= 180 minute(s) starts after start of "Occurrence A of Physical Exam, Finding: Time of Symptom Onset"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>OR: "Medication, Administered: Thrombolytic (t-PA) Therapy (route: 'Intravenous route')"</li>
                              <li>OR: "Procedure, Performed: Intravenous Thrombolytic (t-PA) Therapy"</li>
                              <li>  &lt;= 2 day(s) starts before start of "Occurrence A of Encounter, Performed: Emergency Department Visit"</li>
                           </ul>
                           
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
         </ul>
         
      </div>
      <h3><a name="d1e2700" href="#toc">Data criteria (QDM Data Elements)</a></h3>
      <div>
         
         <ul>
            <li>
               "Diagnosis, Active: Hemorrhagic Stroke" using "Hemorrhagic Stroke Grouping Value Set (2.16.840.1.113883.3.117.1.7.1.212)"
            </li>
            <li>
               "Diagnosis, Active: Ischemic Stroke" using "Ischemic Stroke Grouping Value Set (2.16.840.1.113883.3.117.1.7.1.247)"
            </li>
            <li>
               "Encounter, Performed: Emergency Department Visit" using "Emergency Department Visit SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.292)"
            </li>
            <li>
               "Encounter, Performed: Non-Elective Inpatient Encounter" using "Non-Elective Inpatient Encounter SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.424)"
            </li>
            <li>
               "Laboratory Test, Result: INR" using "INR LOINC Value Set (2.16.840.1.113883.3.117.1.7.1.213)"
            </li>
            <li>
               "Laboratory Test, Result: Partial Thromboplastin Time" using "Partial Thromboplastin Time LOINC Value Set (2.16.840.1.113762.1.4.1045.25)"
            </li>
            <li>
               "Laboratory Test, Result: Platelet Count" using "Platelet Count LOINC Value Set (2.16.840.1.113883.3.117.1.7.1.267)"
            </li>
            <li>
               "Laboratory Test, Result: Prothrombin Time" using "Prothrombin Time LOINC Value Set (2.16.840.1.113762.1.4.1045.24)"
            </li>
            <li>
               "Medication, Administered not done: Medical Reason" using "Medical Reason SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.473)"
            </li>
            <li>
               "Medication, Administered not done: Patient Refusal" using "Patient Refusal SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.93)"
            </li>
            <li>
               "Medication, Administered: Thrombolytic (t-PA) Therapy" using "Thrombolytic (t-PA) Therapy RXNORM Value Set (2.16.840.1.113883.3.117.1.7.1.226)"
            </li>
            <li>
               "Medication, Order not done: Medical Reason" using "Medical Reason SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.473)"
            </li>
            <li>
               "Medication, Order not done: Patient Refusal" using "Patient Refusal SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.93)"
            </li>
            <li>
               "Medication, Order: Thrombolytic (t-PA) Therapy" using "Thrombolytic (t-PA) Therapy RXNORM Value Set (2.16.840.1.113883.3.117.1.7.1.226)"
            </li>
            <li>
               "Medication, Order: t-PA ingredient specific" using "t-PA ingredient specific RXNORM Value Set (2.16.840.1.113762.1.4.1021.6)"
            </li>
            <li>
               "Patient Characteristic Birthdate: birth date" using "birth date LOINC Value Set (2.16.840.1.113883.3.560.100.4)"
            </li>
            <li>
               "Physical Exam, Finding: Baseline State" using "Baseline State SNOMEDCT Value Set (2.16.840.1.113883.3.117.1.7.1.417)"
            </li>
            <li>
               "Physical Exam, Finding: Diastolic Blood Pressure" using "Diastolic Blood Pressure LOINC Value Set (2.16.840.1.113883.3.526.2.1045)"
            </li>
            <li>
               "Physical Exam, Finding: Systolic Blood Pressure" using "Systolic Blood Pressure LOINC Value Set (2.16.840.1.113883.3.526.2.1044)"
            </li>
            <li>
               "Physical Exam, Finding: Time of Symptom Onset" using "Time of Symptom Onset SNOMEDCT Value Set (2.16.840.1.113762.1.4.1045.14)"
            </li>
            <li>
               "Procedure, Performed: Intravenous Thrombolytic (t-PA) Therapy" using "Intravenous Thrombolytic (t-PA) Therapy SNOMEDCT Value Set (2.16.840.1.113762.1.4.1045.15)"
            </li>
            <li>
               "Risk Category Assessment: National Institute of Health Stroke Scale" using "National Institute of Health Stroke Scale LOINC Value Set (2.16.840.1.113883.3.117.1.7.1.269)"
            </li>
            <li>
               Attribute: "Route: Intravenous route" using "Intravenous route SNOMEDCT Value Set  (2.16.840.1.113883.3.117.1.7.1.222)"
            </li>
            <li>
               Attribute: "Ordinality: Principal" using "Principal SNOMEDCT Value Set  (2.16.840.1.113883.3.117.1.7.1.14)"
            </li>
         </ul>
         
      </div>
      <h3><a name="d1e3603" href="#toc">Reporting Stratification</a></h3>
      <div>
         
         <ul>
            <li>None</li>
         </ul>
         
      </div>
      <h3><a name="d1e3625" href="#toc">Supplemental Data Elements</a></h3>
      <div>
         
         <ul>
            <li>
               "Patient Characteristic Ethnicity: Ethnicity" using "Ethnicity CDCREC Value Set (2.16.840.1.114222.4.11.837)"
            </li>
            <li>
               "Patient Characteristic Payer: Payer" using "Payer SOP Value Set (2.16.840.1.114222.4.11.3591)"
            </li>
            <li>
               "Patient Characteristic Race: Race" using "Race CDCREC Value Set (2.16.840.1.114222.4.11.836)"
            </li>
            <li>
               "Patient Characteristic Sex: ONC Administrative Sex" using "ONC Administrative Sex AdministrativeSex Value Set (2.16.840.1.113762.1.4.1)"
            </li>
         </ul>
         
      </div><br><hr align="left" color="teal" size="2" width="80%"><br><table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Set</span></td>
               <td colspan="3" width="80%">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto;word-wrap:break-word">eMeasure Stroke (eSTK)</div>
               </td>
            </tr>
         </tbody>
      </table>
   </body>
</html>